Junko sells SCTY 50.19: GlycoMimetics Announces Presentation of Rivipansel Data in Pediatric Patients at American Society of Pediatric Hematology Oncolo ...
GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that data from a Phase 2 clinical trial of its lead drug candidate rivipansel (GMI-1070) in pediatric patients has been presented at the American Society of Pediatric Hematology Oncology (ASPHO ... ...
59 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home